Up to 7 years treatment with GLP-1 receptor agonist in patients with type 2 diabetes didn't seem to increase pancreatic cancer risk in a large population-based cohort study.
GLP-1s may not raise short-term pancreatic cancer risk for adults with type 2 diabetes healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Analysis links high BMI in late teens to chronic kidney disease ajc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ajc.com Daily Mail and Mail on Sunday newspapers.